Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$113,824 | -$119,119 | -$103,163 | -$97,574 |
| Dep. & Amort. | $447 | $458 | $469 | $327 |
| Deferred Tax | $112,514 | $0 | -$112,514 | $0 |
| Stock-Based Comp. | $22,793 | $18,296 | $18,003 | $15,507 |
| Change in WC | -$10,076 | $1,279 | $29,908 | -$11,584 |
| Other Non-Cash | -$122,913 | -$10,911 | $103,163 | -$7,305 |
| Operating Cash Flow | -$111,059 | -$109,997 | -$64,134 | -$100,629 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$799 | -$629 | -$775 | -$714 |
| Net Acquisitions | -$847 | -$28,939 | $252,805 | $847 |
| Inv. Purchases | -$226,187 | -$367,861 | -$605,803 | -$320,677 |
| Inv. Sales/Matur. | $319,426 | $396,800 | $352,998 | $293,900 |
| Other Inv. Act. | $847 | $28,939 | -$252,805 | -$847 |
| Investing Cash Flow | $92,440 | $28,310 | -$253,580 | -$27,491 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $24,391 | $2,659 | $18,396 | $442,451 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $19,867 | $2,659 | $18,396 | $442,451 |
| Financing Cash Flow | $19,867 | $2,659 | $18,396 | $442,451 |
| Forex Effect | -$196,155 | $0 | $196,155 | $0 |
| Net Chg. in Cash | $1,248 | -$79,028 | -$299,318 | $314,331 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $184,575 | $263,603 | $562,921 | $248,590 |
| End Cash | $185,823 | $184,575 | $263,603 | $562,921 |
| Free Cash Flow | -$111,858 | -$110,626 | -$64,909 | -$101,343 |